After the rapid spread of SARS-CoV-2 in Wuhan, China, at the beginning of 2020, about 1.5
million confirmed cases and over 80,000 deaths have been reported around 200 countries …

An adequate immune response to severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is crucial to not only clear the virus but also prevent tissue immunopathology …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel beta-coronavirus
that has emerged and caused a global pandemic of coronavirus disease 2019 (COVID-19) …

In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus
(SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information on …

Persistence of protective immunity for SARS-CoV-2 is important against reinfection.
Knowledge on SARS-CoV-2 immunity in pediatric patients is currently lacking. We opted to …

The newly identified strain of the Coronaviridae family called severe acute respiratory
syndrome (SARS-CoV-2) recently became the most significant health threat for adults and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses spread
unscrupulously virtually every corner on the planet in a very quick speed leading to an …

Background: The outbreak of coronavirus disease 2019 (COVID-19) is becoming a global
threat. However, our understanding of the clinical characteristics and treatment of critically ill …

The incidence of COVID-19 in children and teenagers is only about 2% in China. Children
had mild symptoms and hardly infected other children or adults. It is worth considering that …

Abstract Children with Coronavirus Disease 2019 (COVID-19) were reported to show milder
symptoms and better prognosis than their adult counterparts, but the difference of immune …